Menu

About Us
GeM Registration
Company Insights

NA Tender by Employees State Insurance Corporation (esic) (GEM/2025/B/6165236)

Amikacin antibiotic disc,Aztreonam antibiotic disc,Amoxycillin and Clavulinic acid,Ampicillin antib

Kollam, Kerala
Goods
Qty:15K
NA Tender by Employees State Insurance Corporation (esic) (GEM/2025/B/6165236)

Tender Timeline

Tender Issue
April 24, 2025 at 9:40 AM

Tender Title: ANTI BIOTIC DISCS

Tender Reference Number: GEM/2025/B/6165236

Issuing Authority

The issuing authority for this tender is the Ministry of Labour and Employment.

Scope of Work and Objectives

This tender encompasses the procurement of a range of anti-biotic discs that are crucial for testing bacterial resistance in clinical laboratories. The key objective is to ensure the provision of high-quality antibiotic discs for various antibiotics including Amikacin, Aztreonam, Amoxycillin and Clavulinic acid, among others. This initiative aims to enhance diagnostic capabilities in health facilities by providing essential tools for effective laboratory testing.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet specific eligibility requirements including being a registered entity with relevant experience in pharmaceutical supplies, particularly in the provision of laboratory materials. Interested bidders must also ensure compliance with any applicable regulations and standards.

Technical Requirements

Bidders are required to supply a diverse range of anti-biotic discs which includes but is not limited to:

  • Amikacin antibiotic disc
  • Aztreonam antibiotic disc
  • Amoxycillin and Clavulinic acid
  • Bacitracin antibiotic disc
  • Meropenam antibiotic disc
    Additionally, each product offered must meet specified quality standards and be compliant with relevant testing criteria, ensuring their efficacy in clinical settings.

Financial Requirements

All participating bidders should prepare to submit required financial documents that validate their capability to fulfill the obligations outlined in the tender. This includes a detailed pricing schedule based on the total quantity of anti-biotic discs which is approximately 14,950 units.

Document Submission Details

Bidders are to submit their proposals and necessary documents in accordance with the specified guidelines. Electronic submissions may be accepted, and all documents must be provided in the accepted formats.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and provides certain benefits designed to enhance their involvement. Startups are also welcome to submit their proposals, in alignment with the government’s initiatives to bolster economic growth and innovation within the healthcare sector.

Evaluation Process

The evaluation process for this tender will involve both technical and financial assessment based on set criteria. Proposals will be scored and ranked accordingly, placing significant emphasis on the quality standards, compliance with specifications, and pricing.

Delivery Locations

Successful bidders will be expected to deliver the anti-biotic discs to designated health facilities across the country as per the instructions provided in the contract agreement.

Contact Information

For further details regarding the tender, including submission guidelines and inquiries, please refer to the official contact points provided in the tender documentation.

This tender offers an essential opportunity to contribute to the enhancement of healthcare services through the reliable supply of critical laboratory resources, fulfilling both quality and compliance needs essential for effective medical practices.

General Information

Item Category
Amikacin antibiotic disc , Aztreonam antibiotic disc , Amoxycillin and Clavulinic acid , Ampicillin antibiotic disc , Bacitracin antibiotic disc , Cefepime antibiotic disc , Cefexime antibiotic disc , Cefoxitin antibiotic disc , Ceftazidime antibiotic disc , Ceftriaxone antibiotic disc , Cefotaxime antibiotic disc , Ciprofloxacin antibiotic disc , Clindamycin antibiotic disc , Colistin antibiotic disc , Cefoperazone and Sulbactam , Cotrimaxazole antibiotic disc , Erythromycin antibiotic disc , Gentamicin antibiotic disc , Imipenam antibiotic disc , Nitrofurantoin antibiotic disc , Norfloxacin antibiotic disc , Oxidase disc antibiotic disc , Optochin disc antibiotic disc , Penicillin antibiotic disc , Piperacillin antibiotic disc , Piperacillin and Tazobactam , Teicoplanin antibiotic disc , Tetracycline antibiotic disc , Vancomycin antibiotic disc , Meropenam antibiotic disc , Tigecycline antibiotic disc , Fosfomycin antibiotic disc , Ceftazidime and Avibatam , Chloramphinicol antibiotic disc , Minocycline antibiotic disc , Doxycycline antibiotic disc , Ertapenam antibiotic disc , Linezolid antibiotic disc , Gentamicin 120 mcg antibiotic disc , Cefazolin 30mcg antibiotic disc , Ampicillin and Sulbactum 10 and10 mcg , Cefuroxime 30mcg antibiotic disc , Tobramycin 10mcg antibiotic disc , Cefiderecol antibiotic disc , Imipenam and Relebactam , Ceftaroline antibiotic disc , Daptomycin antibiotic disc
Ministry Name
Ministry of Labour and Employment
Department Name
NA
Organisation Name
Employees State Insurance Corporation (esic)
State
Kerala
City
Kollam

Financial Information

Bid Offer Validity
60 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7767516.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Inj Adrenaline,Inj Amikacin,Inj Amphoteracin,Inj Aminophylline,Inj Artisunate 60 mg Vial,Inj Atracu

GEM
Goods
Qty:31.5L
6 Files
N/a
CENTRAL DELHI, DELHI
Boq › Boql
Inj Adrenaline , Inj Amikacin , Inj Amphoteracin , Inj Aminophylline , Inj Artisunate 60 mg Vial , Inj Atracurium Besylate , Inj Atropine Sulphate , Inj Ampicillin 500 mg Vial , Inj Amoxy 1 gm with Clavulanic Acid , Inj Anti Rabies Vaccine , Inj Anti Tetanus Vaccine , Inj Amphoteracin B Lipid Complex , Inj Azithromycin 500 mg Vial , Inj Acyclovir 250 mg , Inj Acyclovir 500 mg , Inj Aztreonam 1 gm Vial , Inj Adenosine , Inj Amiodarone , Inj Ascorbic Acid , Inj Amphotericin , Inj Bupivacaine in Dextrose , Inj Bupivacaine , Inj Benzathine Penicillin , Inj Caspofungin 50 mg Vial , Inj Cefepime 1 gm Vial , Inj Cefoperazone 500 mg and Sulbactum 500mg , Inj Cefuroxime Sod. 750 mg Vial , Inj Clindamycin 600 mg per 4 ml Amp , Inj Ceftazidime 1 gm Vial , Inj Cefotaxime 1 gm , Inj Ceftriaxone 1 gm , Inj Calcium Gluconate 100 mg per ml , Inj Colistin Methanosulfonate 1 MIU , Inj Diltiazem 5 mg per ml , Inj Dexmedetomidine 200 mcgper 2 ml , Inj Digoxin 0.25 mg per ml , Inj Dexamethasone 4 mg per 2 ml Vial , Inj Diazepam 5 mg per ml , Inj Diclofenac Sodium 25 mg per ml , Inj Diclofenac Sodium 75 mg per ml , Water for Injection 5 ml Amp , Inj Dopamine Hcl 40 mg per ml , Inj Doxycycline 100 mg Vial , Inj Etophylline 169 mg with Theophylline , Inj Ferric Carboxymaltose 500 mg per 10 ml Vial , Inj Esmolol 10 mg per ml Vial , Inj Enoxaparin 40 mg , Inj Enoxaparin 60 mg , Inj Frusemide 10 mg per ml , Inj Ganciclovir Lyophilised 500 mg Vial , Inj Gentamycin 80 mg per 2 ml , Inj Glycopyrrolate 0.2 mg per ml , Inj Haloperidol 5 mg per ml , Inj Heparin 25000 IUper 5 ml , Inj Hydrocortisone 100 mg Vial , Inj Hyoscine Butyl Bromide 20 mg per ml , Inj Insulin Glargine 100 IUperml , Inj Insulin Mixtard , Inj Insulin NPH Lente , Inj Insulin Plain , Inj Imipenam 500 mg with Cilastatin 500 mg Vial , Inj Isoprenaline 2 mg per ml , Inj Ketamine , Inj L Ornithine L Aspartate , Inj Lignocaine 2 percent 50 ml , Inj Lignocaine 20 mg with Adrenaline , Inj Lignocaine Plain , Inj Labetalol 20 mg per 4 ml , Inj Levetiracetam 500 mlper 5 ml , Inj Methyl Prednisolone Acetate 500 mg Vial , Inj Methyl Prednisolone Acetate 1000 mg Vial , Inj Methyl Prednisolone 40 mg , Inj Metoprolol Tartrate 1 mg per ml , Inj Meropenam 1 gm Vial , Inj Magnessium Sulphate 500 mg per ml , Inj Mephentermine 30 mg per ml , Inj Metaclopramide 5 mg per ml , Inj Methyl Ergometrine , Inj Midazolam 5 mg per ml , Inj Multi Vitamin , In. Noradrenaline 4 mg per ml , Inj Neostigamine 0.5 mg per ml , Inj Nitroglycerine 1 mg per ml , Inj Octreotide 50 mcg Amp , Inj Ondensterone 2 mg per ml , Inj Oxytocin 5 IUper ml , Inj Pantoprazole 40 mg per 10 ml , Inj Phenaramine Maleate , Inj Phenobarbitone 200 mg per ml , Inj Phenytoin Sodium 50 mg per ml , Inj Phenylephrine Hcl 10 mg per ml , Inj Pipracillin 4 gm with Tazobactum , Inj Potassium Chloride 150 mg per 10 ml , Inj Pralidoxime , Inj Promethazine Hcl 25 ml , Inj Propofol 1 percent , Inj Ranitidine 25 mg per ml , Inj Rocuronium Bromide 10 mg per ml , Inj Sodabicarb 7.5 percent , Inj Sodium Valporate 100 mg per 5 ml , Inj Thiopentone Sodium 1 gm Vial , Inj Tiecoplanin 400 mg Vial , Inj Tiecoplanin 200 mg per 3 ml Vial , Inj Tigecycline 50 mg Vial , Inj Tranexanic Acid 100 mg per ml , Inj Thiamine 100 mg per 2 ml , Inj Vacuronium Bromide 4 mg per 2 ml , Inj Vasopressin 20 IU Amp. , Inj Vancomycin 500 mg Vial
April 11, 2025
May 2, 2025 at 4:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity in the pharmaceutical industry, with demonstrable experience in supplying laboratory materials such as anti-biotic discs. Bidders must also comply with any legal or regulatory frameworks pertinent to healthcare supplies.

The technical specifications require that all anti-biotic discs meet stringent quality standards essential for laboratory testing. Each product must demonstrate compliance with prescribed testing criteria, ensuring effective performance in clinical diagnostics.

Bidders must follow the specified submission guidelines outlined in the tender documents. Documents should be submitted electronically, if allowed, and must be clearly labelled while adhering to the accepted document formats to ensure a smooth evaluation process.

Bidders will need to prepare and submit financial documentation that includes an Earnest Money Deposit (EMD) and performance security where specified. This is to ensure financial accountability during the contract execution period, reflecting the bidder’s commitment to fulfilling the requirements of the tender.

Yes, the tender includes provisions that support participation from Micro, Small, and Medium Enterprises (MSEs) as well as startups. These benefits are designed to encourage innovation and expand opportunities in the pharmaceutical sector, aligning with government initiatives for economic growth.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders